Coherus Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.About CHRS
Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.
CHRS Key Statistics
Stock Snapshot
With a market cap of 266.8M, Coherus Oncology(CHRS) trades at $1.82. The stock has a price-to-earnings ratio of -1.19.
As of 2026-05-05, Coherus Oncology(CHRS) stock has fluctuated between $1.82 and $1.82. The current price stands at $1.82, placing the stock 0.0% above today's low and 0.0% off the high.
Coherus Oncology(CHRS) shares are trading with a volume of 207, against a daily average of 916.96K.
In the last year, Coherus Oncology(CHRS) shares hit a 52-week high of $2.62 and a 52-week low of $0.71.
In the last year, Coherus Oncology(CHRS) shares hit a 52-week high of $2.62 and a 52-week low of $0.71.
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.